Sorterad på relevans Sortera på datum
Resultat 1 - 1 av 1
Resultat 1 - 1 av 1
Oblique Therapeutics has entered a research collaboration agreement with Eli Lilly and Company to apply the AbiProt[®] technology to generate antibodies to a high-value target
Sammanhang: ...Oblique Therapeutics has entered a research collaboration agreement with Eli Lilly and Company to apply the AbiProt[®] technology to generate antibodies to a high-value target...
di.se - https://www.di.se/pr...-with-eli/ - 0 - Datum: 2024-08-22 13:16. - Leta efter artikeln på Archive.today »